A meta-analysis of 17 studies of HIV pre-exposure prophylaxis (PrEP) in gay men and other men who have sex with men (MSM) has found that, while PrEP protected them from HIV, the proportion diagnosed with gonorrhoea, chlamydia or syphilis increased significantly in the period between starting PrEP and follow-up, with an average length of time on PrEP at follow-up of six months.
Healthcare providers are missing opportunities to prescribe pre-exposure prophylaxis (PrEP) to patients at high risk of HIV, according to US research published in Clinical Infectious Diseases.
It’s not just HIV stigma – sexism, racism and poverty stigma commonly reported by women living with HIV in the United States
Women living with HIV perceive many forms of stigma in addition to HIV-related stigma, according to a qualitative study published in the July edition of Social Science & Medicine. Stigma related to living with HIV intersected with stigma associated with gender, race, poverty, incarceration and obesity, according to the interviewees.
A rapid increase in pre-exposure prophylaxis (PrEP) use by gay men in Melbourne and Sydney has been accompanied by an equally rapid decrease in consistent condom use, according to an article published online in The Lancet HIV. The changes in behaviour between 2016 and 2017 occurred across the gay community, not only in PrEP users – a significant increase in condomless sex with casual partners was observed in HIV-negative men who were not taking PrEP.
Hepatitis B or raised liver enzymes predict liver toxicity when TB prevention drug is combined with HIV treatment
The risk of liver toxicity in people with HIV taking antiretroviral therapy and isoniazid preventive therapy for tuberculosis is strongly associated with either hepatitis B co-infection or pre-existing liver enzyme elevations, according to international research published in the 1 May edition of the Journal of Acquired Immune Deficiency Syndromes.
Australian HIV-negative gay men express far more confidence in pre-exposure prophylaxis (PrEP) than an undetectable viral load in preventing HIV, with only 18% agreeing that “a person with an undetectable viral load cannot pass on HIV” and 6% feeling comfortable having condomless sex with an HIV-positive partner who had an undetectable viral load, according to a pair of articles recently published in Sexually Transmitted Infections and AIDS and Behavior.
A third of young men who have sex with men (MSM) who take pre-exposure prophylaxis (PrEP) discontinue it within a six-month period, investigators from the United States report in AIDS and Behavior. Common reasons for stopping included being unable to get an appointment with a doctor and problems with insurance coverage.
Loss of kidney function in men with HIV is most strongly associated with antiretroviral therapy, an 11-year study of men living with HIV and their HIV-negative counterparts has found. The study found that men with HIV lost twice as much of their kidney function each year as men without HIV – although the average rate of loss was less than 1% a year.
Potential interactions between ART and other medications present in over half of older HIV-positive people
Over half of older HIV-positive people are at risk of experiencing an interaction between their anti-HIV drugs and medications taken for the treatment of non-HIV-related conditions, Italian investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes.